Chris Eso is Vice President of Coronary and Structural Hearth (CSH) Strategy, Growth and Business Development for Medtronic. Previously, Chris held the title for Vice President of Corporate Development, specifically covering the Cardiac and Vascular Group business units, including Cardiac Rhythm and Heart Failure (CRHF), Coronary and Structure Heart (CSH), and Aortic, Peripheral Vascular and endoVenous (APV). Chris joined Medtronic in August of 2011 and has held numerous positions of increasing responsibility and scope over his tenure at Medtronic.

Chris has more than 18 years of successful professional experience, of increasing responsibilities, with the majority of his experience in a business/corporate development and strategy capacity within the pharmaceutical and medical device industries, in addition to Medtronic, including Allergan, Watson, Agilent Technologies and Peregrine Pharmaceuticals.

Chris holds an MBA from Concordia University and BA in Public Relations, Communications from California State University, Fullerton.